Colesevelam for Children With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 236 participants.
Also called NCT01258075
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 236 participants
- Sponsor
- Registry
-
NCT01258075
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01258075. Randomized; double masking; primary purpose treatment. Start 2011-02-24 (actual); primary completion 2019-11-01 (actual). Results posted on 2020-12-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colesevelam for Children With Type 2 Diabetes
- Acronym
- WELKid DM
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- High-dose colesevelam
- Intervention (Drug)
- Low-dose colesevelam
- Lead sponsor
- Daiichi Sankyo
Record details
- Record id
cardio:ct-nct01258075- Content hash
0bdc3123997c4f58d25f8c9096dab7785e3a5268e25d221056c04d28c3176d1f